Variable CD34(+) recovery of cryopreserved allogeneic HPC products: transplant implications during the COVID-19 pandemic

Donor registries and transplantation societies recommend cryopreservation of unrelated donor hemopoietic progenitor cell (HPC) products before the recipient commences conditioning therapy to mitigate the donor and travel risks associated with the COVID-19 pandemic. However, little is known regarding...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Blood Adv
Autors principals: Purtill, Duncan, Antonenas, Vicki, Chiappini, Paul, Tong, Daochen, O’Flaherty, Elizabeth, Bajel, Ashish, Kabani, Karieshma, Larsen, Stephen, Tan, Suikeat, Hutchins, Cheryl, Curtis, David J., Kennedy, Glen A., Watson, Anne-Marie, Bai, LiJun, Greenwood, Matthew, Gottlieb, David J., Hamad, Nada
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2020
Matèries:
Transplantation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7479963/
https://ncbi.nlm.nih.gov/pubmed/32886750
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020002431
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars